SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018007
Filing Date
2019-05-09
Accepted
2019-05-09 16:17:06
Documents
80
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-10q_20190331.htm 10-Q 2547333
2 EX-31.1 chrs-ex311_6.htm EX-31.1 16158
3 EX-31.2 chrs-ex312_8.htm EX-31.2 16294
4 EX-32.1 chrs-ex321_7.htm EX-32.1 10876
  Complete submission text file 0001564590-19-018007.txt   9199254

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT chrs-20190331.xml EX-101.INS 2070819
6 XBRL TAXONOMY EXTENSION SCHEMA chrs-20190331.xsd EX-101.SCH 62996
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chrs-20190331_cal.xml EX-101.CAL 79975
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chrs-20190331_def.xml EX-101.DEF 249552
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20190331_lab.xml EX-101.LAB 459820
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20190331_pre.xml EX-101.PRE 405089
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 19810779
SIC: 2836 Biological Products, (No Diagnostic Substances)